iiinova — where your digital self keeps evolving

Davide Capodanno

@dfcapodanno.bsky.social

Professor of Cardiology at University of Catania, Italy. Director Division of Cardiology at Policlinico Hospital, Catania. Editor-in-Chief of EuroIntervention.

Posts Replies Media

Davide Capodanno @dfcapodanno.bsky.social · 23/01/2025

We authored the editorial “Science Behind the Study” for @NEJM, focusing on the AZALEA-TIMI 71 trial, a phase 2b study of the Factor XI inhibitor abelacimab in patients with atrial fibrillation.

020

Davide Capodanno @dfcapodanno.bsky.social · 06/01/2025

A clinical consensus statement from the EAPCI outlining procedural and technical requirements to enhance the efficacy and safety of PCI in patients with reduced ejection fraction deemed not suitable for CABG. eurointervention.pcronline.com/article/high...

022

Davide Capodanno @dfcapodanno.bsky.social · 21/12/2024

There is everything you might expect (e.g., bifurcations, chronic total occlusions, drug-coated balloons), but also something surprising (inflammation, robotics, artificial intelligence), in the 2024 ranking of the most trending papers on EuroIntervention.

042

Davide Capodanno @dfcapodanno.bsky.social · 16/12/2024

With the expanded indications for TAVI, a growing number of patients may outlive their initial transcatheter heart valve. This review addresses key considerations for lifetime management of these patients. eurointervention.pcronline.com/article/life...

032

Davide Capodanno @dfcapodanno.bsky.social · 06/12/2024

Are all stents the same for high bleeding risk patients? We wrote a brief article on the topic. www.tandfonline.com/doi/full/10....

020

Davide Capodanno @dfcapodanno.bsky.social · 05/12/2024

When I saw the results of the TCW trial at EuroPCR, I thought the results were too good to be true. The NI margin seemed too wide, and I doubted we would see the paper published anytime soon, let alone in a high-impact journal. But here we are – it’s in The Lancet. www.thelancet.com/journals/lan...

010

Davide Capodanno @dfcapodanno.bsky.social · 04/12/2024

After SENIOR RITA, I still have doubts about treating older patients with acute coronary syndromes. Although the trial was formally neutral, those treated with an invasive strategy had fewer spontaneous re-infarctions. We just published this debate. eurointervention.pcronline.com/article/elde...

083